ESMO President: What to watch for at ESMO 2021
ESMO President: What to watch for at ESMO 2021
Nivolumab plus ipilimumab shows benefit over chemo for unresectable malignant pleural mesothelioma
OncoAlert and ecancer weekly round up for August 2 - August 14, 2021
Predicting survival in NSCLC patients with poor performance status in resource-constrained settings
Oncogenesis: Lung cancer
Immunotherapy in lung cancer
OncoAlert and ecancer weekly round up for July 19 - July 25, 2021
Unmet medical needs and emerging data on EGFR exon 20 insertion mutation NSCLC at ASCO 2021
Lineage plasticity in lung cancer- biological and therapeutic implications
CodeBreaK 100: Patient-reported outcomes evaluating sotorasib in KRAS p.G12C mNSCLC
ASCO 2021: Lung roundup
Latest updates in exon 20 insertions focusing on targeted therapies, novel approaches, and implications for patients